Next Generation Sequencing Key Players | Innovation and Product Evolution | Market Entry and Expansion Strategies | Investment and Capital Allocation | Technology Commercialization | Market Trends Analysis | Future Market Positioning

Next Generation Sequencing Manufacturers and Market Growth

The global next generation sequencing market size is calculated at US$ 10.27 billion in 2024, grew to US$ 12.51 billion in 2025, and is projected to reach around US$ 73.47 billion by 2034. The market is expanding at a CAGR of 21.74% between 2024 and 2034.

Top Companies in the Next Generation Sequencing:

• Illumina
• BGI
• Eurofins GATC Biotech GmbH
• Perkin Elmer, Inc.
• DNASTAR, Inc.
• Genomatix GmbH
• PierianDx
• Oxford Nanopore Technologies
• Bio-Rad Laboratories, Inc.
• QIAGEN
• F. Hoffman-La Roche Ltd.
• Thermo Fisher Scientific, Inc.

Latest Announcements by Industry Leaders

• In October 2024, in order to make sequencing more affordable for more research and testing laboratories, medical equipment manufacturer Illumina opened a new tab and revealed its new line of smaller, benchtop gene sequencers.

Recent Developments in the Next Generation Sequencing Market

• In October 2024, the MiSeq i100 Series of sequencing equipment was introduced by Illumina, a multinational corporation dedicated to DNA sequencing and array-based technologies. The new systems are designed to improve next-generation sequencing (NGS) capabilities for labs by providing quick turnaround and user-friendliness.
• In August 2023, as part of the Almac Group, Almac Diagnostic Services announced an investment to give BioPharma partners access to more Next Generation Sequencing (NGS) capabilities.

If you have any questions, please feel free to contact us at sales@towardshealthcare.com